In patients with IPF, TGF-β1 expression is particularly high in fibrotic areas of the lungs, and TGF-β1 drives the expression of genes that encode key ECM components, including collagen, fibronectin, and α-SMA9–11. This evidence concerns the gene FN1 and idiopathic pulmonary fibrosis.